Bioatla Inc (BCAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,961 | 7,118 | 8,320 | 18,207 | 32,363 |
| TOTAL | $3,093 | $8,013 | $9,670 | $20,613 | $37,537 |
| Non-Current Assets | |||||
| PPE Net | N/A | 120 | 324 | 380 | 495 |
| Other Non-Current Assets | 5,473 | 5,695 | 5,914 | 6,136 | 258 |
| TOTAL | $5,473 | $5,815 | $6,238 | $6,516 | $753 |
| Total Assets | $8,566 | $13,828 | $15,908 | $27,129 | $38,290 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 19,133 | 16,353 | 16,811 | 15,795 | 15,452 |
| Other current liabilities | N/A | 4,142 | N/A | N/A | N/A |
| TOTAL | $20,692 | $21,922 | $17,984 | $16,600 | $16,006 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 25,183 | 28,095 | 29,161 | 27,274 | 21,737 |
| TOTAL | $25,183 | $28,095 | $29,161 | $27,274 | $21,737 |
| Total Liabilities | $45,875 | $50,017 | $47,145 | $43,874 | $37,743 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,657 | 1,657 | 1,176 | 1,174 | 1,168 |
| Common Shares | N/A | N/A | 6 | 6 | 6 |
| Retained earnings | -551,990 | -545,646 | -535,862 | -520,084 | -501,373 |
| TOTAL | $-37,309 | $-36,189 | $-31,237 | $-16,745 | $547 |
| Total Liabilities And Equity | $8,566 | $13,828 | $15,908 | $27,129 | $38,290 |